Home › Compare › MEDIF vs VICI

MEDIF vs VICI: Dividend Comparison 2026

MEDIF yields 4345.46% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDIF wins by $15969693446287.80M in total portfolio value
10 years
MEDIF
MEDIF
● Live price
4345.46%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15969693446288.79M
Annual income
$15,278,069,441,942,714,000.00
Full MEDIF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — MEDIF vs VICI

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDIFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDIF + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MEDIF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF
Annual income on $10K today (after 15% tax)
$369,364.48/yr
After 10yr DRIP, annual income (after tax)
$12,986,359,025,651,306,000.00/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, MEDIF beats the other by $12,986,359,025,650,776,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + VICI for your $10,000?

MEDIF: 50%VICI: 50%
100% VICI50/50100% MEDIF
Portfolio after 10yr
$7984846723144.89M
Annual income
$7,639,034,720,971,668,000.00/yr
Blended yield
95.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

MEDIF
No analyst data
Altman Z
-2.9
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys
0
VICI buys
0
No recent congressional trades found for MEDIF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDIFVICI
Forward yield4345.46% ✓6.57%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$15969693446288.79M ✓$988.8K
Annual income after 10y$15,278,069,441,942,714,000.00 ✓$623,261.32
Total dividends collected$15922667488789.34M ✓$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MEDIF vs VICI ($10,000, DRIP)

YearMEDIF PortfolioMEDIF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$445,246$434,546.44$11,368$948.43+$433.9K → MEDIF
2$18,558,681$18,082,267.04$13,339$1,493.16+$18.55M → MEDIF
3$724,251,944$704,394,155.22$16,326$2,426.21+$724.24M → MEDIF
4$26,465,566,588$25,690,617,008.13$21,123$4,112.15+$26465.55M → MEDIF
5$905,687,152,836$877,368,996,586.58$29,379$7,368.23+$905687.12M → MEDIF
6$29,029,592,495,582$28,060,507,242,048.22$44,804$14,191.64+$29029592.45M → MEDIF
7$871,632,797,918,927$840,571,133,948,653.80$76,658$29,972.12+$871632797.84M → MEDIF
8$24,520,223,407,609,444$23,587,576,313,836,190.00$150,894$71,015.81+$24520223407.46M → MEDIF
9$646,377,574,155,211,500$620,140,935,109,069,400.00$350,814$193,582.47+$646377574154.86M → MEDIF
10$15,969,693,446,288,792,000$15,278,069,441,942,714,000.00$988,809$623,261.32+$15969693446287.80M → MEDIF

MEDIF vs VICI: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this MEDIF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHDMEDIF vs JEPIMEDIF vs OMEDIF vs KOMEDIF vs MAINMEDIF vs NNNMEDIF vs EPRTMEDIF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.